Alex Gorsky, the CEO of one of the world's largest pharmaceutical companies Johnson & Johnson, is stepping down in January 2022 ...
A recently approved Biogen Alzheimer’s drug, Aduhelm® (Aducanumab), raises questions about the ethics of a laissez-faire, ...
The accelerated approval of Biogen’s Alzheimer’s drug, Aduhelm®, has been controversial, in part due to its significant side ...
Specialists Losing Trust in FDA Following Alleged Unbiasedness in New Drug Approval Process According to a survey conducted by ...
In April 2020, the FDA requested the removal of all prescription and over-the-counter (OTC) ranitidine drugs from the market ...
As previously spoken about, Zantac lawsuits and litigation has grown after the Zantac recall by the FDA due to the levels of NDMA ...
